Malaria Pan/Pf antigen rapid kit
- UID
- MFG/IVD/2022/000045_35879e72979e5fa7451acfa9a5088a30_4d5c4ca019d683df2d88e3efcb1a9e31
- Device class
- Class C
- License holder
- Promea Therapeutics Private Limited
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- Malaria Pan/Pf Ag Rapid Test is a lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of Plasmodium falciparum ##PLACEHOLDER_0## antigen and P. vivax ##PLACEHOLDER_0##, P. ovale ##PLACEHOLDER_0##, or P. malaria ##PLACEHOLDER_0## antigen in human blood specimen. This device is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with plasmodium
Malaria Pan/Pf antigen rapid kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000045_35879e72979e5fa7451acfa9a5088a30_4d5c4ca019d683df2d88e3efcb1a9e31. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.